Palisade Bio (PALI) Intangibles (2010 - 2021)
Palisade Bio's (PALI) quarterly Intangibles came in at $141642.0 in Q1 2021, down 78.2% year-on-year from $649745.0 in Q1 2020, and down 3.73% on a QoQ basis from $147133.0 in Q4 2020.
Palisade Bio (PALI) Intangibles (2010 - 2021) Analysis & Trends
Palisade Bio (PALI) has 12 years of Intangibles data on file, last reported at $141642.0 in Q1 2021.
- On a quarterly basis, Intangibles fell 78.2% year-over-year to $141642.0 in Q1 2021; TTM through Mar 2021 was $141642.0, a 78.2% decrease from a year earlier, with the FY2020 full-year figure at $147133.0, down 78.0% from the prior year.
- Intangibles for Q1 2021 stood at $141642.0, down from $147133.0 in the prior quarter.
- Over the last five years, Intangibles for PALI reached as high as $945066.0 in Q2 2017 and fell as low as $141642.0 in Q1 2021.
- Historically, Intangibles has averaged $669691.8 across 5 years, with a median of $738404.0 in 2019.
- Across the five-year window, Intangibles fell 6.98% in 2017 and sank 78.2% in 2021, its largest moves.
- Year by year, Intangibles stood at $883462.0 in 2017, then retreated by 13.57% to $763543.0 in 2018, then slipped by 12.39% to $668936.0 in 2019, then slumped by 78.0% to $147133.0 in 2020, then slipped by 3.73% to $141642.0 in 2021.
- Per Business Quant data, the three most recent Intangibles figures were $141642.0 in Q1 2021, $147133.0 in Q4 2020, and $152625.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 141,642.00 |
| Dec 31, 2020 | 147,133.00 |
| Sep 30, 2020 | 152,625.00 |
| Jun 30, 2020 | 630,554.00 |
| Mar 31, 2020 | 649,745.00 |
| Dec 31, 2019 | 668,936.00 |
| Sep 30, 2019 | 688,127.00 |
| Jun 30, 2019 | 713,265.00 |
| Mar 31, 2019 | 738,404.00 |
| Dec 31, 2018 | 763,543.00 |
| Sep 30, 2018 | 788,733.00 |
| Jun 30, 2018 | 814,023.00 |
| Mar 31, 2018 | 839,314.00 |
| Dec 31, 2017 | 883,462.00 |
| Sep 30, 2017 | 915,457.00 |
| Jun 30, 2017 | 945,066.00 |
| Mar 31, 2017 | 904,732.00 |
| Dec 31, 2016 | 990,153.00 |
| Sep 30, 2016 | 984,125.00 |
| Jun 30, 2016 | 1.03 Mn |